Analysis Article • Jul 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 17, 2026
DataAggregated Company Financials
Companies6
- 7D5.7%
- 3M-22.9%
- 1Y-21.4%
- YTDn/a
The Drug Retail industry is up 5.7% in the last week, with Fangzhou up 9.5%. However, the industry is down 21% over the past year. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 18 Jul 2026 | HK$201.1b | HK$143.2b | HK$8.7b | 31.4x | 23.1x | 1.4x |
| Mon, 15 Jun 2026 | HK$199.3b | HK$143.3b | HK$8.7b | 33.8x | 22.8x | 1.4x |
| Wed, 13 May 2026 | HK$245.4b | HK$141.1b | HK$8.7b | 42.6x | 28.3x | 1.7x |
| Fri, 10 Apr 2026 | HK$267.8b | HK$140.2b | HK$8.6b | 46.4x | 31.1x | 1.9x |
| Sun, 08 Mar 2026 | HK$269.8b | HK$139.1b | HK$7.7b | 37.9x | 35.1x | 1.9x |
| Tue, 03 Feb 2026 | HK$333.6b | HK$128.7b | HK$6.9b | 46.5x | 48.4x | 2.6x |
| Thu, 01 Jan 2026 | HK$296.5b | HK$127.2b | HK$6.8b | 38x | 43.5x | 2.3x |
| Sat, 29 Nov 2025 | HK$324.8b | HK$125.8b | HK$6.7b | 42.4x | 48.2x | 2.6x |
| Mon, 27 Oct 2025 | HK$335.6b | HK$122.1b | HK$6.1b | 61x | 54.7x | 2.7x |
| Wed, 24 Sep 2025 | HK$371.7b | HK$122.4b | HK$6.2b | 66.9x | 60.4x | 3x |
| Fri, 22 Aug 2025 | HK$343.3b | HK$121.6b | HK$5.2b | 56.9x | 66.2x | 2.8x |
| Sun, 20 Jul 2025 | HK$260.1b | HK$115.3b | HK$4.5b | 48.4x | 57.7x | 2.3x |
| Tue, 17 Jun 2025 | HK$239.7b | HK$115.4b | HK$4.5b | 49.1x | 53.2x | 2.1x |
| Thu, 15 May 2025 | HK$240.1b | HK$111.9b | HK$4.2b | 66x | 56.9x | 2.1x |
| Sat, 12 Apr 2025 | HK$208.4b | HK$109.7b | HK$4.1b | 58.5x | 50.4x | 1.9x |
| Mon, 10 Mar 2025 | HK$225.2b | HK$108.0b | HK$5.3b | 47.1x | 42.7x | 2.1x |
| Wed, 05 Feb 2025 | HK$176.3b | HK$104.4b | HK$3.6b | 40.8x | 48.8x | 1.7x |
| Fri, 03 Jan 2025 | HK$147.7b | HK$103.5b | HK$3.6b | 35.3x | 41.2x | 1.4x |
| Sun, 01 Dec 2024 | HK$170.7b | HK$104.4b | HK$3.6b | 38.7x | 47.2x | 1.6x |
| Tue, 29 Oct 2024 | HK$176.2b | HK$104.5b | HK$3.3b | 49.7x | 53.1x | 1.7x |
| Thu, 26 Sep 2024 | HK$161.6b | HK$106.2b | HK$3.4b | 44.2x | 47.9x | 1.5x |
| Sat, 24 Aug 2024 | HK$132.3b | HK$104.8b | HK$3.3b | 36.3x | 39.8x | 1.3x |
| Mon, 22 Jul 2024 | HK$136.9b | HK$101.8b | HK$2.4b | 42.2x | 57.4x | 1.3x |
| Wed, 19 Jun 2024 | HK$151.2b | HK$102.0b | HK$2.4b | 45.6x | 63.3x | 1.5x |
| Fri, 17 May 2024 | HK$170.9b | HK$103.8b | HK$2.3b | 50.4x | 73.3x | 1.6x |
| Sun, 14 Apr 2024 | HK$139.7b | HK$103.9b | HK$2.3b | 41.8x | 59.9x | 1.3x |
| Tue, 12 Mar 2024 | HK$167.7b | HK$105.2b | -HK$1,457,377,637.80 | 55.5x | -115.1x | 1.6x |
| Thu, 08 Feb 2024 | HK$161.4b | HK$106.3b | -HK$1,472,437,358.46 | 52.4x | -109.6x | 1.5x |
| Sat, 06 Jan 2024 | HK$188.5b | HK$105.9b | -HK$1,467,392,922.00 | 58.4x | -128.4x | 1.8x |
| Mon, 04 Dec 2023 | HK$202.1b | HK$105.8b | -HK$1,466,070,775.00 | 63.8x | -137.9x | 1.9x |
| Wed, 01 Nov 2023 | HK$204.5b | HK$101.8b | -HK$1,735,688,250.00 | 85.4x | -117.8x | 2x |
| Fri, 29 Sep 2023 | HK$214.3b | HK$102.4b | -HK$1,676,082,900.00 | 102x | -127.9x | 2.1x |
| Sun, 27 Aug 2023 | HK$233.4b | HK$102.2b | -HK$1,954,934,659.00 | 75x | -119.4x | 2.3x |
| Tue, 25 Jul 2023 | HK$267.3b | HK$96.1b | -HK$4,169,620,928.00 | 117.8x | -64.1x | 2.8x |
Price to Earnings Ratio
-64.1x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.1x which is lower than its 3-year average PE of 98.4x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 2.18% | |
| Consumer Staples | 5.26% | |
| Food and Staples Retail | 5.25% | |
| Drug Retail | 5.65% | |
| Big Box Super Stores | 10.84% | |
| Food Retail | 4.73% | |
| Food Distributors | -2.92% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6086 Fangzhou | HK$0.81 | 9.5% +HK$97.0m | -79.0% | PE82x | |
| 314 Sipai Health Technology | HK$1.47 | 6.5% +HK$66.1m | -77.2% | PS0.5x |